You are here

Cancer drug 'may fight inherited dementia'

Cancer drug 'may fight inherited dementia'
1st June 2011

A potential cancer treatment could be used to fight inherited dementia, research has shown.

Scientists from the University of Texas Southwestern Medical Center have found that Suberoylanilide hydroxamic acid (SAHA) has promise as a drug for the prevention and treatment of familial frontotemporal dementia (FTD).

This is a progressive, inherited neurodegenerative disease which has no cure. SAHA is currently approved for use against a cancer called cutaneous T-cell lymphoma.

"We found a drug that can overcome the chemical deficiency associated with the condition, and we showed that it worked in cells taken from humans with FTD," said co-author Dr Gang Yu.

This follows comments by one expert who advises that people should eat healthily to stave off dementia.

Dr Simon Ridley, head of research at Alzheimer's Research UK, said that while no research suggests that one particular food can stave off the condition, increased cardiovascular risk factors are linked to a higher risk.

Find the nearest Barchester care home